Titre : Adénocarcinome

Adénocarcinome : Questions médicales fréquentes

Termes MeSH sélectionnés :

alpha-Fetoproteins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome : Questions médicales les plus fréquentes", "headline": "Adénocarcinome : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Adénocarcinome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2024-12-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Adénocarcinome" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carcinomes", "url": "https://recherchemedicale.com/mesh/D002277", "about": { "@type": "MedicalCondition", "name": "Carcinomes", "code": { "@type": "MedicalCode", "code": "D002277", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome à cellules claires", "alternateName": "Adenocarcinoma, Clear Cell", "url": "https://recherchemedicale.com/mesh/D018262", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome à cellules claires", "code": { "@type": "MedicalCode", "code": "D018262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.045" } } }, { "@type": "MedicalWebPage", "name": "Adénocarcinome folliculaire", "alternateName": "Adenocarcinoma, Follicular", "url": "https://recherchemedicale.com/mesh/D018263", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome folliculaire", "code": { "@type": "MedicalCode", "code": "D018263", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.060" } } }, { "@type": "MedicalWebPage", "name": "Adénocarcinome papillaire", "alternateName": "Adenocarcinoma, Papillary", "url": "https://recherchemedicale.com/mesh/D000231", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome papillaire", "code": { "@type": "MedicalCode", "code": "D000231", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Carcinome papillaire folliculaire", "alternateName": "Carcinoma, Papillary, Follicular", "url": "https://recherchemedicale.com/mesh/D018265", "about": { "@type": "MedicalCondition", "name": "Carcinome papillaire folliculaire", "code": { "@type": "MedicalCode", "code": "D018265", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.085.225" } } } ] }, { "@type": "MedicalWebPage", "name": "Adénocarcinome squirrheux", "alternateName": "Adenocarcinoma, Scirrhous", "url": "https://recherchemedicale.com/mesh/D002293", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome squirrheux", "code": { "@type": "MedicalCode", "code": "D002293", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.095" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Linite plastique", "alternateName": "Linitis Plastica", "url": "https://recherchemedicale.com/mesh/D008039", "about": { "@type": "MedicalCondition", "name": "Linite plastique", "code": { "@type": "MedicalCode", "code": "D008039", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.095.410" } } } ] }, { "@type": "MedicalWebPage", "name": "Carcinome à cellules acineuses", "alternateName": "Carcinoma, Acinar Cell", "url": "https://recherchemedicale.com/mesh/D018267", "about": { "@type": "MedicalCondition", "name": "Carcinome à cellules acineuses", "code": { "@type": "MedicalCode", "code": "D018267", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.215" } } }, { "@type": "MedicalWebPage", "name": "Carcinome adénoïde kystique", "alternateName": "Carcinoma, Adenoid Cystic", "url": "https://recherchemedicale.com/mesh/D003528", "about": { "@type": "MedicalCondition", "name": "Carcinome adénoïde kystique", "code": { "@type": "MedicalCode", "code": "D003528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.220" } } }, { "@type": "MedicalWebPage", "name": "Cholangiocarcinome", "alternateName": "Cholangiocarcinoma", "url": "https://recherchemedicale.com/mesh/D018281", "about": { "@type": "MedicalCondition", "name": "Cholangiocarcinome", "code": { "@type": "MedicalCode", "code": "D018281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.450" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeur de Klatskin", "alternateName": "Klatskin Tumor", "url": "https://recherchemedicale.com/mesh/D018285", "about": { "@type": "MedicalCondition", "name": "Tumeur de Klatskin", "code": { "@type": "MedicalCode", "code": "D018285", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.450.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Porocarcinome eccrine", "alternateName": "Eccrine Porocarcinoma", "url": "https://recherchemedicale.com/mesh/D057090", "about": { "@type": "MedicalCondition", "name": "Porocarcinome eccrine", "code": { "@type": "MedicalCode", "code": "D057090", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.470.200.025.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Adénocarcinome", "alternateName": "Adenocarcinoma", "code": { "@type": "MedicalCode", "code": "D000230", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nora Katabi", "url": "https://recherchemedicale.com/author/Nora%20Katabi", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA." } }, { "@type": "Person", "name": "Ying Wang", "url": "https://recherchemedicale.com/author/Ying%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China." } }, { "@type": "Person", "name": "Chaoqiang Deng", "url": "https://recherchemedicale.com/author/Chaoqiang%20Deng", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China." } }, { "@type": "Person", "name": "Yuan Li", "url": "https://recherchemedicale.com/author/Yuan%20Li", "affiliation": { "@type": "Organization", "name": "Institute of Thoracic Oncology, Fudan University, Shanghai, China." } }, { "@type": "Person", "name": "Yang Zhang", "url": "https://recherchemedicale.com/author/Yang%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.", "datePublished": "2023-04-05", "url": "https://recherchemedicale.com/article/37017469", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.5883" } }, { "@type": "ScholarlyArticle", "name": "Clinically Applicable Homogeneous Assay for Serological Diagnosis of Alpha-Fetoprotein by Impact Electrochemistry.", "datePublished": "2022-10-14", "url": "https://recherchemedicale.com/article/36240195", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acssensors.2c01887" } }, { "@type": "ScholarlyArticle", "name": "The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.", "datePublished": "2022-11-28", "url": "https://recherchemedicale.com/article/36456455", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jfma.2022.11.006" } }, { "@type": "ScholarlyArticle", "name": "A functionalized magnetic nanoparticle regulated CRISPR-Cas12a sensor for the ultrasensitive detection of alpha-fetoprotein.", "datePublished": "2022-07-12", "url": "https://recherchemedicale.com/article/35697344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2an00697a" } }, { "@type": "ScholarlyArticle", "name": "Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.", "datePublished": "2024-05-08", "url": "https://recherchemedicale.com/article/38785709", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/bios14050235" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://recherchemedicale.com/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par type histologique", "item": "https://recherchemedicale.com/mesh/D009370" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs épithéliales épidermoïdes et glandulaires", "item": "https://recherchemedicale.com/mesh/D009375" }, { "@type": "ListItem", "position": 5, "name": "Carcinomes", "item": "https://recherchemedicale.com/mesh/D002277" }, { "@type": "ListItem", "position": 6, "name": "Adénocarcinome", "item": "https://recherchemedicale.com/mesh/D000230" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Adénocarcinome - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Adénocarcinome", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Adénocarcinome", "description": "Comment diagnostique-t-on un adénocarcinome ?\nQuels tests sont utilisés pour confirmer un adénocarcinome ?\nQuels marqueurs tumoraux sont associés à l'adénocarcinome ?\nL'imagerie joue-t-elle un rôle dans le diagnostic ?\nPeut-on détecter un adénocarcinome par un examen physique ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Adénocarcinome", "description": "Quels sont les symptômes courants d'un adénocarcinome ?\nL'adénocarcinome provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques selon l'organe touché ?\nComment l'adénocarcinome affecte-t-il l'appétit ?\nLes symptômes de l'adénocarcinome sont-ils toujours visibles ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Adénocarcinome", "description": "Peut-on prévenir l'adénocarcinome ?\nQuels facteurs de mode de vie influencent le risque ?\nLes dépistages réguliers aident-ils à prévenir l'adénocarcinome ?\nL'exercice physique joue-t-il un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir certains adénocarcinomes ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Adénocarcinome", "description": "Quels traitements sont disponibles pour l'adénocarcinome ?\nLa radiothérapie est-elle efficace contre l'adénocarcinome ?\nQuand la chimiothérapie est-elle recommandée ?\nY a-t-il des traitements ciblés pour l'adénocarcinome ?\nLes traitements sont-ils personnalisés pour chaque patient ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Adénocarcinome", "description": "Quelles sont les complications possibles de l'adénocarcinome ?\nL'adénocarcinome peut-il affecter d'autres organes ?\nComment l'adénocarcinome impacte-t-il la qualité de vie ?\nLes traitements peuvent-ils causer des complications ?\nQuelles sont les complications à long terme ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Adénocarcinome", "description": "Quels sont les principaux facteurs de risque de l'adénocarcinome ?\nLe sexe influence-t-il le risque d'adénocarcinome ?\nLes antécédents médicaux augmentent-ils le risque ?\nL'exposition à des substances chimiques est-elle un facteur de risque ?\nLe régime alimentaire influence-t-il le risque d'adénocarcinome ?", "url": "https://recherchemedicale.com/mesh/D000230?mesh_terms=alpha-Fetoproteins&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un adénocarcinome ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par biopsie, imageries médicales et analyses histologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer un adénocarcinome ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie, la tomodensitométrie et l'IRM." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont associés à l'adénocarcinome ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le CA 19-9 et le CEA peuvent indiquer un adénocarcinome." } }, { "@type": "Question", "name": "L'imagerie joue-t-elle un rôle dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'imagerie aide à localiser la tumeur et à évaluer son extension." } }, { "@type": "Question", "name": "Peut-on détecter un adénocarcinome par un examen physique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique peut révéler des masses ou des anomalies, mais un test complémentaire est nécessaire." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'un adénocarcinome ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fatigue, perte de poids et changements digestifs." } }, { "@type": "Question", "name": "L'adénocarcinome provoque-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur peut survenir selon la localisation et l'avancement de la maladie." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques selon l'organe touché ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par exemple, des saignements pour le côlon ou des toux persistantes pour les poumons." } }, { "@type": "Question", "name": "Comment l'adénocarcinome affecte-t-il l'appétit ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut entraîner une perte d'appétit et des nausées, affectant la nutrition." } }, { "@type": "Question", "name": "Les symptômes de l'adénocarcinome sont-ils toujours visibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains adénocarcinomes peuvent être asymptomatiques à un stade précoce." } }, { "@type": "Question", "name": "Peut-on prévenir l'adénocarcinome ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures comme une alimentation saine et l'arrêt du tabac peuvent réduire le risque." } }, { "@type": "Question", "name": "Quels facteurs de mode de vie influencent le risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'obésité et une alimentation riche en graisses sont des facteurs de risque." } }, { "@type": "Question", "name": "Les dépistages réguliers aident-ils à prévenir l'adénocarcinome ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les dépistages peuvent détecter des anomalies précoces et améliorer les chances de traitement." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire le risque de plusieurs types de cancers, y compris l'adénocarcinome." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir certains adénocarcinomes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations, comme celle contre le HPV, peuvent réduire le risque de cancers associés." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'adénocarcinome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace contre l'adénocarcinome ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour réduire la taille des tumeurs ou soulager la douleur." } }, { "@type": "Question", "name": "Quand la chimiothérapie est-elle recommandée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle est souvent utilisée après la chirurgie pour éliminer les cellules cancéreuses restantes." } }, { "@type": "Question", "name": "Y a-t-il des traitements ciblés pour l'adénocarcinome ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des thérapies ciblées peuvent être utilisées selon les caractéristiques génétiques de la tumeur." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés pour chaque patient ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction du type et du stade du cancer." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'adénocarcinome ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la métastase, l'obstruction des organes et des douleurs chroniques." } }, { "@type": "Question", "name": "L'adénocarcinome peut-il affecter d'autres organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut se propager à d'autres organes, entraînant des complications graves." } }, { "@type": "Question", "name": "Comment l'adénocarcinome impacte-t-il la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Il peut entraîner des douleurs, des limitations physiques et des impacts psychologiques." } }, { "@type": "Question", "name": "Les traitements peuvent-ils causer des complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des effets secondaires significatifs." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications à long terme peuvent inclure des récidives et des effets secondaires des traitements." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de l'adénocarcinome ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le tabagisme, l'obésité et des antécédents familiaux." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'adénocarcinome ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains types d'adénocarcinome sont plus fréquents chez un sexe que l'autre." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies inflammatoires ou de cancers augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à des substances chimiques est-elle un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des agents carcinogènes comme l'amiante peut augmenter le risque." } }, { "@type": "Question", "name": "Le régime alimentaire influence-t-il le risque d'adénocarcinome ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses et pauvre en fibres peut augmenter le risque." } } ] } ] }

Sources (4493 au total)

Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.

To characterize alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) at the single-cell level and to identify regulatory factors for AFP expression and malignancy.... ScRNA-seq was performed on two tumors collected from patients with AFPGC. InferCNV and sub-clustering were applied to identify typical AFPGC cells, followed by AddModuleScore, pathway enrichment, Pseu... AFPGC cells are similar to hepatocytes in transcriptome and transcriptional regulation, with kinetic malignancy-related pathways, compared to the common malignant epithelium. In addition, compared to ... We demonstrated the single-cell characteristics of AFPGC and that DKK1 facilitates AFP expression and malignancy....

The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.

Alpha fetoprotein (AFP) is the most widely used tumor marker for hepatocellular carcinoma (HCC). Nevertheless, few studies have investigated the prognostic factors of HCC patients with normal serum AF... We retrospectively enrolled 2198 patients with HCC and normal serum AFP levels (<20 ng/mL) from 2007 to 2020. Overall survival (OS) rates were calculated by the Kaplan-Meier method, and analyses of th... Among the enrolled patients, 1385 (63%) patients were in the low-normal AFP group (serum AFP levels ≤7 ng/mL), and 813 (37%) patients were in the high-normal AFP group (serum AFP levels between 7 and ... Liver functional reserve, anti-viral therapy, tumor size, vascular invasion, and treatment modalities, determined the outcomes of HCC patients with normal serum AFP levels, but serum AFP levels did no...

Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.

Resection of Barcelona Clinic Liver Cancer (BCLC) intermediate-stage hepatocellular carcinoma (HCC) remains controversial. While not recommended by the BCLC algorithm, some patients may indeed benefit... Intermediate-stage HCC patients who underwent curative-intent resection were identified from an international multi-institutional database. Factors associated with long-term prognosis were identified ... Among 194 patients, most individuals had two tumors (n = 123, 63.4%) with a median size of 6.0 cm (IQR, 4.0-8.4) for a median tumor burden score (TBS) of 6.5 (IQR, 5.0-9.1); median alpha-fetoprotein (... Long-term OS and RFS outcomes varied considerably. Using a simple risk score, patients with low AFP and low TBS were identified as the subset of individuals most likely to benefit from resection....

Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.

Apparently healthy individuals with elevated serum alpha-fetoprotein (AFP) levels (>7 ng/mL) for unknown causes visit clinics. We investigated their clinical characteristics, outcomes, and relationshi... The case group included asymptomatic 137 individuals with "elevated AFP level" (R772) diagnostic code from 2009 to 2018 in a tertiary hospital. The control group enrolled 274 age- and sex-matched pati... The case group (mean age 47.5 years, male 35.8%) showed higher AFP levels (10.3 vs 2.5 ng/mL, p<0.001) and total bilirubin (0.8 vs 0.7 mg/dL, p<0.001), but a lower body mass index (22.2 vs 23.3 kg/m2,... Elevated AFP levels in asymptomatic individuals may play a role in expressing a protective phenotype against hepatic steatosis, myosteatosis, and sarcopenia. AFP levels in patients with elevated AFP w...

Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.

Hepatoid adenocarcinoma of the stomach (HAS) is a highly malignant and rare extrahepatic tumor. The prognosis is controversial because of its rarity and the lack of multi-center cohort studies, especi... We retrospectively reviewed clinical data of one HAS patient treated at our institution in 2019 and of 252 patients reported between 1984 and 2020 in research databases.... Among these patients, 60.1% were > 60 years, 51% had lesions in the gastric antrum, and 51.0% (73/143) had the ulcerative lesion type. The preoperative elevated levels of serum alpha-fetoprotein (AFP)... Liver metastasis was increasingly more likely with increasingly higher serum AFP, but the prognosis of HAS is not necessarily poor. Serum AFP level is an important prognostic indicator in HAS and shou...